DECISION OF THE EEA JOINT COMMITTEE No 198/2020
of 11 December 2020
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2000]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2020/42 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance bambermycin as regards its maximum residue limit ( 1 ) is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 amending Regulation (EU) No 37/2010 to classify the substance ciclesonide as regards its maximum residue limit ( 2 ) is to be incorporated into the EEA Agreement.
(3) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
‘—
32020 R 0042 : Commission Implementing Regulation (EU) 2020/42 of 17 January 2020 ( OJ L 15, 20.1.2020, p. 2 ),
— 32020 R 0043 : Commission Implementing Regulation (EU) 2020/43 of 17 January 2020 ( OJ L 15, 20.1.2020, p. 5 ).’
Article 2
The texts of Implementing Regulations (EU) 2020/42 and (EU) 2020/43 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.
Article 3
This Decision shall enter into force on 12 December 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 11 December 2020.
For the EEA Joint Committee
The President
Sabine MONAUNI
( 1 ) OJ L 15, 20.1.2020, p. 2 .
( 2 ) OJ L 15, 20.1.2020, p. 5 .
( *1 ) No constitutional requirements indicated.
Feedback